Skip to main content
SpringerLink
Log in

Thrombophile Gerinnungsstörungen

  • Chapter
Transfusionsmedizin

  • 243 Accesses

Zusammenfassung

Unter dem Begriff »Thrombophilie« werden diejenigen Störungen zusammengefasst, bei denen mit einem erhöhten Risiko für venöse Thrombosen und Embolien zu rechnen ist. Im Allgemeinen wird die Bezeichnung Thrombophilie für die Thromboseneigung des venösen Schenkels des Gefäßssystems verwendet, bei bestimmten Formen der Thrombophilie können jedoch auch gehäuft Thrombosen in der arteriellen Gefäßbahn auftreten, insbesondere in den Hirnarterien und Herzkranzgefäßen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baudo F, DeGasperi A, deCataldo F, Caimi TM, Cattaneo D, Redaelli R, Pannacciulli E, Corti A, Mazza E, Belli L (1992) Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial. Thromb Res 68: 409–416

    Article  PubMed  CAS  Google Scholar 

  2. Bergmann F, Hoyer PF, Vigano D’Angelo S, Mazzola G, Oestereich C, Bartheis M, D’Angelo A (1995) Severe autoimmune protein S deficiency in boy with idiopathic purpura fulminans. Br J Haemat 89: 610–614

    Article  CAS  Google Scholar 

  3. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez- Rodriguez A, Steingrub JS, Garber GE, Heiterbrand JD, Ely EW, Fisher CJ Jr (2001) For the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709

    Article  PubMed  CAS  Google Scholar 

  4. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64–67

    Article  PubMed  CAS  Google Scholar 

  5. Büller HR, Ten cate JW (1989) Acquired antithrombin III deficinecy: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate. Am J Med 87 (suppl3B): 44S-48S

    Article  PubMed  Google Scholar 

  6. Conard J, Horellou MH, van Dreden P, Lecompte T, Samama M (1990) Thrombosis and pregnancy in congenital deficiencies in Antithrombin III, protein C or protein S: study of 78 women. Thromb Haemostas 63: 319–320

    CAS  Google Scholar 

  7. Conard J, Bauer KA, Gruber A, Griffin JH, Schwarz HP, Horellou MH, Samama MM, Rosenberg RD (1993) Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. Blood 82: 1159–1164

    PubMed  CAS  Google Scholar 

  8. Escuriola-Ettingshausen C, Veldmann A, Beeg T, Schneider W, Jäger G, Kreuz W (1999) Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans. Sem Thromb Hemost 25: 537–541

    Article  Google Scholar 

  9. Finazzi G, Caccia R, Barbui T (1987) Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases. Thromb Haemostas 58: 1094

    CAS  Google Scholar 

  10. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J (1993) Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104: 882–888

    Article  PubMed  CAS  Google Scholar 

  11. Hazelzet JA, de Kleijn ED, de Groot R (2001) Endothelial protein C activation in meningococcal sepsis. N Engl J Med 345: 1777

    Article  Google Scholar 

  12. Langley PG, Hughes RD, Forbes A, Keays R, Williams R (1993) Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepatol 17: 326–331

    Article  PubMed  CAS  Google Scholar 

  13. Lechner K, Kyrle PA (1995) Antithrombin III concentrates — are they clinically useful? Thromb Haemost 73: 340–348

    PubMed  CAS  Google Scholar 

  14. Leclerc F, Hazelzet J, Jude B, Hofhuis W, Hue V, Martinot A, Van der Voort E (1992) Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intens Care Med 18: 202–205

    Article  CAS  Google Scholar 

  15. Melissari E, Kakkar W (1989) Congenital severe protein C deficiency in adults. Br J Haematol 72: 222–228

    Article  PubMed  CAS  Google Scholar 

  16. Menache D, O’Malley JP, Schorr JB, Wagner B, Williams C, and the Cooperative Study Group (1990) Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Blood 75: 33–39

    PubMed  CAS  Google Scholar 

  17. Pabinger I, Brücker S, Kyrle PA, Schneider B, Korninger C, Niessner H, Lechner K (1992) Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for a rational patient screening. Blood Coagul Fibrinol 3: 547–553

    Article  CAS  Google Scholar 

  18. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K (1994) The risk of thromboembolism in asymptomatic patients with protein C- and protein S deficiency: A prospective cohort study. Thromb Haemostas 71: 441–445

    CAS  Google Scholar 

  19. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88: 3698 – 3703

    Google Scholar 

  20. Rintala E, Kauppila M, Seppala OP, Voipio-Pulkki LM, Pettila V, Rasi V, Kotilainen P (2000) Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med 28: 2373–2378

    Article  PubMed  CAS  Google Scholar 

  21. Sanz-Rodriguez C, Gil-Fernandez Jj, Zapater P, Pinilla I, Granados E, de Gomez G, Soria V, Cano J, Sala N, Fernandez-Ranada JM, Gomez-Gomez N (1999) Long-term management of homozygous protein C deficiency: replacement therapy with subcutaneous purified protein C concentrate. Thromb Haemost 81: 887–890

    PubMed  CAS  Google Scholar 

  22. Schramm W, Spannagl M, Bauer KA, Rosenberg RD, Birkner B, Linnau Y, Schwarz HP (1993) Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate. Arch Dermatol 129: 753–756

    Article  PubMed  CAS  Google Scholar 

  23. Trobisch H, Wüst T (2001) Antithrombin. In: Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten, 2. Aufl. Herausgegeben vom Vorstand und Wissenschaftlichen Beirat der Bundesärztekammer, Köln, S 151–164

    Google Scholar 

  24. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286: 1869–1878

    Article  PubMed  CAS  Google Scholar 

  25. White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP (2000) An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 96: 3719–3724

    PubMed  CAS  Google Scholar 

  26. Willeke A, Gerdsen F, Bauersachs RM, Lindhoff-Last E (2002) Rationelle Thrombophiliediagnostik. Dtsch Ärztebl 99: C 1685–1690

    Google Scholar 

Download references

Authors
  1. I. Pabinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Finkenweg 15, 35440, Linden, Deutschland

    Christian Mueller-Eckhardt

  2. Klinik und Poliklinik für Innere Medizin, Abteilung Transfusionsmedizin, Universitätsklinikum Rostock, Ernst-Heydemann-Str. 6, 18057, Rostock, Deutschland

    Volker Kiefel

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pabinger, I. (2004). Thrombophile Gerinnungsstörungen. In: Mueller-Eckhardt, C., Kiefel, V. (eds) Transfusionsmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10597-9_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10597-9_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10598-6

  • Online ISBN: 978-3-662-10597-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation